LA JOLLA, Calif. and CLEVELAND, May14, 2015 \/PRNewswire\/ -- Human Longevity, Inc.(HLI)and Cleveland Clinic today announced a broad collaboration agreement to first sequence and analyze blood samples from Cleveland Clinic's GeneBank study of de-identified patients. <\/p>\n
The two organizations will apply whole genome, cancer and microbiome sequencing focusing on a subset of samples with the goal of discovering novel disease genes and disease pathways associated with heart disease. <\/p>\n
\"Cleveland Clinic is one of the premier clinical health care settings in the world and we are excited to be working with Dr. Cosgrove and his team. Using HLI's powerful genomic technologies and analysis tools to better understand the biological basis for disease should enable earlier intervention and better treatments,\" said J. Craig Venter, Ph.D., CEO of HLI. <\/p>\n
\"In medicine we are constantly exploring opportunities to better understand how diseases develop and what we can do to either prevent or provide the most impactful and effective course of treatment,\" said Toby Cosgrove, M.D., President and CEO of Cleveland Clinic. \"We are thrilled to be advancing the correlation of genomic data with clinical care.\" <\/p>\n
HLI is currently sequencing and analyzingthousands of whole genomesper month.The company is integrating this whole genome sequence data with extensive and unique clinical measures and imaging within the HLI Knowledgebase. The combined high quality, comprehensive data will continue to enrich the HLI Knowledgebase, which includes the company's proprietary informatics analysis and data interpretation and integration. The company is pursuing agreements with a variety of customers including pharmaceutical and biotech companies, academic health systems, governments and insurers. <\/p>\n
About Human Longevity, Inc.HLI, a privately held company headquartered in San Diego, CA was founded in 2013 by pioneers in the fields of genomics and stem cell therapy. Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building the world's most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline. HLI will be licensing access to its database, and developing new diagnostics and therapeutics as part of their product offerings. For more information please visit, http:\/\/www.humanlongevity.com<\/a> <\/p>\n About Cleveland ClinicCleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S. News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual \"America's Best Hospitals\" survey. More than 3,000 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. The Cleveland Clinic health system includes a main campus near downtown Cleveland, eight community hospitals, more than 75 Northern Ohio outpatient locations, including 16 full-service Family Health Centers, Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas, Cleveland Clinic Canada, and, scheduled to begin seeing patients in 2015, Cleveland Clinic Abu Dhabi. In 2013, there were 5.5 million outpatient visits throughout the Cleveland Clinic health system and 157,000 hospital admissions. Patients came for treatment from every state and from more than 130 countries. Visit us at http:\/\/www.clevelandclinic.org.Follow<\/a> us at http:\/\/www.twitter.com\/ClevelandClinic<\/a>. <\/p>\n Editor's Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request. <\/p>\n Logo - http:\/\/photos.prnewswire.com\/prnh\/20140304\/LA76169LOGO<\/a> <\/p>\n<\/p>\n <\/p>\n See original here: LA JOLLA, Calif. and CLEVELAND, May14, 2015 \/PRNewswire\/ -- Human Longevity, Inc.(HLI)and Cleveland Clinic today announced a broad collaboration agreement to first sequence and analyze blood samples from Cleveland Clinic's GeneBank study of de-identified patients. The two organizations will apply whole genome, cancer and microbiome sequencing focusing on a subset of samples with the goal of discovering novel disease genes and disease pathways associated with heart disease. Continue reading
\nHuman Longevity, Inc. and Cleveland Clinic Establish Broad ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"